Sentence examples for most frequent regimens from inspiring English sources

Most patients (68.8%) were receiving CT with palliative intent, with taxane monotherapy (15.9%) and gemcitabine monotherapy (10.5%) being the most frequent regimens.

The most frequent regimens among these patients included only a single drug, usually ampicillin-clavulanate (47 patients, 42%), doxycycline (27, 24%), and ceftriaxone (6, 5%).

Most frequent regimens were beta-lactam plus fluoroquinolones (n = 20, 62.5%); beta-lactam plus macrolides (n = 6; 18.7%) and beta-lactam plus linezolid (n = 5, 15.6%).

The most frequent regimens were fluoroquinolones plus β-lactam (n = 217, 63%), β-lactam plus macrolide (n = 73, 21%), fluoroquinolone monotherapy (n = 39, 11%) and β-lactam monotherapy (n = 18, 5%).

In a recent review of antiretroviral use in the Swiss Cohort, Atripla was the most frequent regimen used (28%).

The most common regimens were carboplatin (CBDCA) plus paclitaxel, and cisplatin (CDDP) plus S-1 (46 patients each), and the third most frequent regimen was CDDP plus vinorelbine (VNR) (41 patients).

Basic demographic and clinical characteristics of the breast cancer patients are presented for the two most frequent chemotherapy regimens, and all regimens.

The most frequent chemotherapy regimens used (in 76% of patients) were cisplatin etoposide and cisplatin vinorelbine.

In the non-ICU group, glucocorticoids and cyclophosphamide were the most frequent induction regimen (58.9% of patients).

The most frequent chemotherapy regimen included cyclophosphamide, epirubicin, and 5-fluorouracil and was administered to 49 patients in each group.

Finally, analysis of groups by alkylator regimen revealed significant inverse associations in dichotomous and continuous models between MGMT activity and PFS for the 42 tumors receiving PCV, the most frequent treatment regimen, as well as significant associations for the 42 tumors treated with other alkylating agents (Table 5).